Wallington Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Wallington Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-255	Closed	-$22K	–	114
2014 Q2	$22K	Hold	255	–	–	0.01%	81
2014 Q1	$20K	Buy	+255	New	+$21.2K	0.01%	89

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wallington Asset Management's IBB Position: Q3 2014 in Review

Wallington Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2014, closing a stake of 255 shares — an estimated $22K sold.

Wallington Asset Management first reported a position in IBB in Q1 2014 and held it in 2 quarters. The position peaked at $22K in Q2 2014. 318 funds tracked by Wall St. Rank hold IBB as of Q3 2014.

Wallington Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2014 after selling out during the quarter.
Wallington Asset Management sold 255 iShares Biotechnology ETF shares in Q3 2014, an estimated $22K.
Wallington Asset Management first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 2 quarters.
Wallington Asset Management's iShares Biotechnology ETF position peaked at $22K in Q2 2014.
318 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2014.

Based on Wallington Asset Management's 13F filing for Q3 2014, filed 28 Oct 2014.